These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32514547)

  • 41. Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries.
    Proietti M; Laroche C; Nieuwlaat R; Crijns HJGM; Maggioni AP; Lane DA; Boriani G; Lip GYH; ;
    Eur J Intern Med; 2018 Sep; 55():28-34. PubMed ID: 29778588
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry.
    Malavasi VL; Vitolo M; Proietti M; Diemberger I; Fauchier L; Marin F; Nabauer M; Potpara TS; Dan GA; Kalarus Z; Tavazzi L; Maggioni AP; Lane DA; Lip GYH; Boriani G;
    Eur J Clin Invest; 2022 Jul; 52(7):e13773. PubMed ID: 35305020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
    BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Age-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe: The EORP-AF General Pilot Registry (EURObservational Research Programme-Atrial Fibrillation).
    Fumagalli S; Said SAM; Laroche C; Gabbai D; Marchionni N; Boriani G; Maggioni AP; Popescu MI; Rasmussen LH; Crijns HJGM; Lip GYH;
    JACC Clin Electrophysiol; 2015 Aug; 1(4):326-334. PubMed ID: 29759321
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contemporary management of patients with atrial fibrillation in the Netherlands and Belgium: a report from the EORP-AF long-term general registry.
    Erküner Ö; van Eck M; Xhaet O; Verheij H; Neefs J; Duygun A; Nijmeijer R; Saïd SAM; Uiterwaal H; Hagens V; Bhagwandien R; Szili-Torok T; Bijsterveld N; Tjeerdsma G; Vijgen J; Friart A; Hoffer E; Evrard P; Srynger M; Meeder J; de Groot JR; van Opstal J; Gevers R; Lip GYH; Boriani G; Crijns HJGM; Luermans JGLM; Mairesse GH
    Neth Heart J; 2021 Nov; 29(11):584-594. PubMed ID: 34524620
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Eur J Heart Fail; 2015 Jun; 17(6):570-82. PubMed ID: 25727992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation.
    Chu G; Seelig J; Trinks-Roerdink EM; van Alem AP; Alings M; van den Bemt B; Boersma LV; Brouwer MA; Cannegieter SC; Ten Cate H; Kirchhof CJ; Crijns HJ; van Dijk EJ; Elvan A; van Gelder IC; de Groot JR; den Hartog FR; de Jong JS; de Jong S; Klok FA; Lenderink T; Luermans JG; Meeder JG; Pisters R; Polak P; Rienstra M; Smeets F; Tahapary GJ; Theunissen L; Tieleman RG; Trines SA; van der Voort P; Geersing GJ; Rutten FH; Hemels ME; Huisman MV
    BMJ Open; 2020 Aug; 10(8):e036220. PubMed ID: 32843516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry.
    Rivera-Caravaca JM; Piot O; Roldán-Rabadán I; Denis A; Anguita M; Mansourati J; Pérez-Cabeza A; Marijon E; García-Seara J; Leclercq C; García-Bolao I; Lellouche N; Potpara T; Boriani G; Fauchier L; Lip GYH; Marín F
    Europace; 2022 Feb; 24(2):202-210. PubMed ID: 34374759
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stroke prevention in atrial fibrillation patients in Poland and other European countries: insights from the GARFIELD-AF registry.
    Stępińska J; Kremis E; Konopka A; Wożakowska-Kapłon B; Ruszkowski P; Kukla P; Kayani G
    Kardiol Pol; 2016; 74(4):362-71. PubMed ID: 26365937
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation.
    Lip GY; Laroche C; Boriani G; Cimaglia P; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Popescu MI; Tica O; Hellum CF; Mortensen B; Tavazzi L; Maggioni AP
    Europace; 2015 Jan; 17(1):24-31. PubMed ID: 24957921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology.
    Boriani G; Vitolo M; Lane DA; Potpara TS; Lip GY
    Eur J Intern Med; 2021 Apr; 86():1-11. PubMed ID: 33518403
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF.
    Piccini JP; Fraulo ES; Ansell JE; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey PR; Mahaffey KW; Thomas LE; Kong MH; Lopes RD; Mills RM; Peterson ED
    Am Heart J; 2011 Oct; 162(4):606-612.e1. PubMed ID: 21982650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rationale and design of the First Brazilian Cardiovascular Registry of Atrial Fibrillation: The RECALL study.
    Lopes RD; de Paola AA; Lorga Filho AM; Consolim-Colombo FM; Andrade J; Piva E Mattos LA; Bernardez-Pereira S; Berwanger O; de Oliveira Figueiredo MJ;
    Am Heart J; 2016 Jun; 176():10-6. PubMed ID: 27264215
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Major knowledge gaps and system barriers to guideline implementation among European physicians treating patients with atrial fibrillation: a European Society of Cardiology international educational needs assessment.
    Heidbuchel H; Dagres N; Antz M; Kuck KH; Lazure P; Murray S; Carrera C; Hindricks G; Vahanian A
    Europace; 2018 Dec; 20(12):1919-1928. PubMed ID: 29538637
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions.
    Kirchhof P; Nabauer M; Gerth A; Limbourg T; Lewalter T; Goette A; Wegscheider K; Treszl A; Meinertz T; Oeff M; Ravens U; Breithardt G; Steinbeck G;
    Thromb Haemost; 2011 Jun; 105(6):1010-23. PubMed ID: 21544322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ;
    Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Secondary stroke prevention and guideline adherent antithrombotic treatment in patients with atrial fibrillation: Insights from the Gulf Survey of atrial fibrillation events (Gulf SAFE).
    Miyazawa K; Li YG; Rashed WA; Al Mahmeed W; Shehab A; Zubaid M; Lip GYH
    Int J Cardiol; 2019 Jan; 274():126-131. PubMed ID: 30064925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Management of thromboembolic risk in patients with atrial fibrillation in Italy: baseline data from the PREFER in AF European Registry].
    De Caterina R; Renda G; Sangiuolo R; Attena E; Di Lecce L; Romeo F;
    G Ital Cardiol (Rome); 2014 Feb; 15(2):99-109. PubMed ID: 24625849
    [TBL] [Abstract][Full Text] [Related]  

  • 60. One-year clinical outcome of patients with nonvalvular atrial fibrillation: Insights from KERALA-AF registry.
    Bahuleyan CG; Namboodiri N; Jabir A; Lip GYH; Koshy A G; Shifas BM; Viswanathan S K; Zachariah G; Venugopal K; Punnose E; Natarajan KU; Mini GK; Joseph J; Nambiar C A; Jayagopal PB; Mohanan PP; George R; Unni G; Sajeev CG; Muhammed S; Syam N; Roby A; Daniel R; Krishnakumar VV; Pillai AM; Joseph S; Jinbert Lordson A
    Indian Heart J; 2021; 73(1):56-62. PubMed ID: 33714410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.